Document is current
Any future updates will be listed below
-
Authors
Lütkemeyer, Alexander
Voß, Sabrina
Klag, Franziska
Groß, Joline
Reckmann, Jonas
Gärtner, Anna
Anselmetti, Dario
Gummert, Jan
Walhorn, Volker
Milting, Hendrik
Brodehl, Andreas
-
Funding
Funding for this research was provided by:
Ruhr-Universität Bochum
- License Information
-
More Information
Article History
Received: 19 December 2025
Accepted: 12 March 2026
First Online: 25 March 2026
Declarations
:
: A.B. is a shareholder of Merck, Prime Medicine and Tenaya Therapeutics. The remaining authors have nothing to disclose.
: Not relevant.
